Short description
Specializes in the development of nanoparticles for cancer treatment.
Description
Cello Therapeutics, Inc. (Cello) was founded in April 2016 and specializes in the development of nanoparticles for cancer treatment. Their nanoparticles are composed of FDA-approved cancer drugs loaded within a biocompatible polymer core. These nanoparticles are then coated with natural red blood cell membrane, a recent breakthrough technology in the field of nanomedicine. Appearing as red blood cells to the body, these membrane-coated nanoparticles are able to avoid evoking an immune response while circulating in the bloodstream for an extended period of time for improved drug delivery to tumor sites. With this novel approach to cancer treatment, their products offer unique performance advantages for oncological applications. Currently, the company is in the drug development and testing stage.
Total funding
$$43214321
Sign in for full access
Location
San Diego, California, United States, North America
Founded on
April 1, 2016
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$1230 - 4560
Sign in for full access
Founders
Huiqing Zhu, Jie Zhang, Liangfang Zhang, Lili Xie